These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30178287)

  • 1. Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro.
    Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA
    Neurotox Res; 2019 Jan; 35(1):244-254. PubMed ID: 30178287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitors modulate kynurenic acid production in rat brain cortex in vitro.
    Zakrocka I; Turski WA; Kocki T
    Eur J Pharmacol; 2016 Oct; 789():308-312. PubMed ID: 27423316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain-Its Possible Clinical Applications.
    Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA
    Neurotox Res; 2017 Nov; 32(4):639-648. PubMed ID: 28733707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrolysin lowers kynurenic acid formation--an in vitro study.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of cyclooxygenase inhibitors on kynurenic acid production in rat kidney: a novel path for kidney protection?
    Zakrocka I; Załuska W
    Pharmacol Rep; 2023 Apr; 75(2):376-385. PubMed ID: 36788192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro.
    Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Feb; 392(2):209-217. PubMed ID: 30370429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of three angiotensin-converting enzyme inhibitors on kynurenic acid production in rat kidney in vitro.
    Zakrocka I; Kocki T; Turski WA
    Pharmacol Rep; 2017 Jun; 69(3):536-541. PubMed ID: 28364692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
    Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
    Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenic Acid Levels and Kynurenine Aminotransferase I, II and III Activities in Ganglia, Heart and Liver of Snail Helix Pomatia.
    Kronsteiner C; Baran H; Kepplinger B
    Cell Physiol Biochem; 2023 Aug; 57(4):279-297. PubMed ID: 37597169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
    Bortz DM; Wu HQ; Schwarcz R; Bruno JP
    Neuropharmacology; 2017 Jul; 121():69-78. PubMed ID: 28419874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kynurenine metabolism in Alzheimer's disease.
    Baran H; Jellinger K; Deecke L
    J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kynurenic acid metabolism in the brain of HIV-1 infected patients.
    Baran H; Hainfellner JA; Kepplinger B; Mazal PR; Schmid H; Budka H
    J Neural Transm (Vienna); 2000; 107(10):1127-38. PubMed ID: 11129102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome.
    Baran H; Cairns N; Lubec B; Lubec G
    Life Sci; 1996; 58(21):1891-9. PubMed ID: 8637415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-Cycloserine lowers kynurenic acid formation--new mechanism of action.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):639-44. PubMed ID: 24189377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling.
    Luchowska E; Kloc R; Olajossy B; Wnuk S; Wielosz M; Owe-Larsson B; Urbanska EM
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):519-29. PubMed ID: 19439240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Translational Analysis of Brain Kynurenic Acid Modulation via Irreversible Kynurenine Aminotransferase II Inhibition.
    Chang C; Fonseca KR; Li C; Horner W; Zawadzke LE; Salafia MA; Welch KA; Strick CA; Campbell BM; Gernhardt SS; Rong H; Sawant-Basak A; Liras J; Dounay A; Tuttle JB; Verhoest P; Maurer TS
    Mol Pharmacol; 2018 Aug; 94(2):823-833. PubMed ID: 29853495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II.
    Kocki T; Luchowski P; Luchowska E; Wielosz M; Turski WA; Urbanska EM
    Neurosci Lett; 2003 Jul; 346(1-2):97-100. PubMed ID: 12850557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats.
    Luchowski P; Luchowska E; Turski WA; Urbanska EM
    Neurosci Lett; 2002 Sep; 330(1):49-52. PubMed ID: 12213632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating KYNA production and kynurenergic manipulation on acute mouse brain slice preparations.
    Herédi J; Cseh EK; Berkó AM; Veres G; Zádori D; Toldi J; Kis Z; Vécsei L; Ono E; Gellért L
    Brain Res Bull; 2019 Mar; 146():185-191. PubMed ID: 30639278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.